{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:24:24Z","timestamp":1788279864887,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00467-021-04967-3","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T22:31:30Z","timestamp":1613687490000},"page":"2411-2419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases"],"prefix":"10.1007","volume":"36","author":[{"given":"Kelsey L.","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-286X","authenticated-orcid":false,"suffix":"Jr","given":"Donald J.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan K.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Warady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"4967_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","volume":"52","author":"JT Flynn","year":"2008","unstructured":"Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, Warady BA, Chronic Kidney Disease in Children Study Group (2008) Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 52:631\u2013637","journal-title":"Hypertension"},{"key":"4967_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2009060609","volume":"21","author":"M Mitsnefes","year":"2010","unstructured":"Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, CKiD Study Group (2010) Masked hypertension associate with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137\u2013144","journal-title":"J Am Soc Nephrol"},{"key":"4967_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03130312","volume":"7","author":"TM Brady","year":"2012","unstructured":"Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, White CT, Furth S, Warady BA, Mitsnefes M (2012) Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol 7:1930\u20131937","journal-title":"Clin J Am Soc Nephrol"},{"key":"4967_CR4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"ESCAPE Trial Group, W\u00fchl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, M\u00f6ller K, Wigger M, Peruzzi L, Mehls O, Schaefer F (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639\u20131650","journal-title":"N Engl J Med"},{"key":"4967_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1053\/j.ajkd.2015.01.008","volume":"65","author":"BA Warady","year":"2015","unstructured":"Warady BA, Abraham AG, Schwartz GJ, Wong CS, Mu\u00f1oz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S (2015) Predictors of rapid progression of glomerular and non-glomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis 65:878\u2013888","journal-title":"Am J Kidney Dis"},{"key":"4967_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.117.09649","volume":"71","author":"GM Barletta","year":"2018","unstructured":"Barletta GM, Pierce C, Mitsnefes M, Samuels J, Warady BA, Furth S, Flynn J (2018) Is blood pressure improving in children with chronic kidney disease? A period analysis. Hypertension 71:444\u2013450","journal-title":"Hypertension"},{"key":"4967_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2215\/CJN.08420811","volume":"8","author":"MC Matteucci","year":"2013","unstructured":"Matteucci MC, Chinali M, Rinelli G, W\u00fchl E, Zurowska A, Charbit M, Pongiglione G, Schaefer F, ESCAPE Trial Group (2013) Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol 8:203\u2013210","journal-title":"Clin J Am Soc Nephrol"},{"key":"4967_CR8","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1681\/ASN.2018010036","volume":"29","author":"SM van den Belt","year":"2018","unstructured":"van den Belt SM, HJL H, Gracchi V, de Zeeuw D, W\u00fchl E, Schaefer F, ESCAPE Trial Group (2018) Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol 29:2225\u20132233","journal-title":"J Am Soc Nephrol"},{"key":"4967_CR9","doi-asserted-by":"publisher","first-page":"e0213192","DOI":"10.1371\/journal.pone.0213192","volume":"14","author":"M Jun","year":"2019","unstructured":"Jun M, Jardine MJ, Perkovic V, Pilard Q, Billot L, Rodgers A, Rogers K, Gallagher M (2019) Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study. PLoS One 14:e0213192","journal-title":"PLoS One"},{"key":"4967_CR10","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.mayocp.2019.05.031","volume":"94","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Shin JI, Sang Y, Inker LA, Secora A, Luo S, Coresh J, Alexander GC, Jackson JW, Chang AR, Grams ME (2019) Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Mayo Clin Proc 94:2220\u20132229","journal-title":"Mayo Clin Proc"},{"key":"4967_CR11","doi-asserted-by":"crossref","unstructured":"van den Belt SM, Heerspink HJL, Kirchner M, Gracchi V, Thurn-Valsassina D, Bayazit AK, Niemirska A, Canpolat N, Kaplan Bulut I, Azukaitis K, Duzova A, Bacchetta J, Shroff R, Paripovic D, \u00d6z\u00e7akar ZB, Fidan K, Erdogan H, Gellermann J, W\u00fchl E, de Zeeuw D, Melk A, Querfeld U, Schaefer F (2020) Discontinuation of RAAS inhibition in children with advanced CKD. Clin J Am Soc Nephrol 15:625-632","DOI":"10.2215\/CJN.09750819"},{"key":"4967_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851\u2013860","journal-title":"N Engl J Med"},{"key":"4967_CR13","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"20","author":"JT Wright Jr","year":"2002","unstructured":"Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney Disease, Hypertension Study Group (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 20:2421\u20132431","journal-title":"JAMA"},{"key":"4967_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/j.1552-4604.1996.tb04199.x","volume":"13","author":"K Abbott","year":"1996","unstructured":"Abbott K, Smith A, Bakris GL (1996) Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes. J Clin Pharmacol 13:274\u2013279","journal-title":"J Clin Pharmacol"},{"key":"4967_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/MAJ.0b013e3181c643df","volume":"339","author":"T Nakamura","year":"2010","unstructured":"Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Sugaya T, Yamagishi S, Yamada S, Koide H (2010) Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-Ohdg, urinary L-Fabp, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease. Am J Med Sci 339:157\u2013163","journal-title":"Am J Med Sci"},{"key":"4967_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2215\/CJN.01941205","volume":"1","author":"SK Furth","year":"2006","unstructured":"Furth SK, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Mu\u00f1oz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006\u20131015","journal-title":"Clin J Am Soc Nephrol"},{"key":"4967_CR17","first-page":"140","volume":"e20171904","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on Screening and Management of High Blood Pressure in Children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics e20171904:140","journal-title":"Pediatrics"},{"key":"4967_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/ki.2013.352","volume":"85","author":"AJ Kogon","year":"2014","unstructured":"Kogon AJ, Pierce CB, Cox C, Brady TM, Mitsnefes MM, Warady BA, Furth SL, Flynn JT (2014) Nephrotic range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease. Kidney Int 85:938\u2013944","journal-title":"Kidney Int"},{"key":"4967_CR19","doi-asserted-by":"crossref","unstructured":"Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, Kaskel F, Furth SL, Schwartz GJ, CKiD Investigators (2009) Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol 4:812\u2013819","DOI":"10.2215\/CJN.01780408"},{"key":"4967_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v015.i02","volume":"15","author":"U Halekoh","year":"2006","unstructured":"Halekoh U, H\u00d8jsgaard S, Yan J (2006) The R package geepack for generalized estimating equations. J Statistical Software 15:1\u201311","journal-title":"J Statistical Software"},{"key":"4967_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2215\/CJN.07480714","volume":"10","author":"SA Fathallah-Shaykh","year":"2015","unstructured":"Fathallah-Shaykh SA, Flynn JT, Pierce CB, Abraham AG, Blydt-Hansen TD, Massengill SF, Moxey-Mims MM, Warady BA, Furth SL, Wong CS (2015) Progression of pediatric CKD of non-glomerular origin in the CKiD cohort. Clin J Am Soc Nephrol 10:571\u2013577","journal-title":"Clin J Am Soc Nephrol"},{"key":"4967_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00467-016-3512-4","volume":"32","author":"AG Abraham","year":"2017","unstructured":"Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, Mu\u00f1oz A (2017) Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol 32:643\u2013649","journal-title":"Pediatr Nephrol"},{"key":"4967_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1081\/JDI-120024284","volume":"25","author":"G Bellinghieri","year":"2003","unstructured":"Bellinghieri G, Mazzaglia G, Savica V, Santoro D (2003) Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: A multicenter randomized controlled trial. Ren Fail 25:681\u2013689","journal-title":"Ren Fail"},{"key":"4967_CR24","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1523-1755.2004.00620.x","volume":"65","author":"GL Bakris","year":"2004","unstructured":"Bakris GL, Weir M, Secic M, Campbell B, Weis-McNulty A (2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 65:1991\u20132002","journal-title":"Kidney Int"},{"key":"4967_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.14740\/jocmr3253w","volume":"10","author":"T Okuda","year":"2004","unstructured":"Okuda T, Okamura K, Shirai K, Urata H (2004) Effect of angiotensin-converting enzyme inhibitor\/calcium antagonist combination therapy on renal function in hypertensive patients with chronic kidney disease: Chikushi Anti-Hypertension Trial- Benidipine and Perindopril. J Clin Med Res 10:117\u2013124","journal-title":"J Clin Med Res"},{"key":"4967_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/hr.2010.221","volume":"34","author":"M Abe","year":"2011","unstructured":"Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M (2011) Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. Hypertens Res 34:268\u2013273","journal-title":"Hypertens Res"},{"key":"4967_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/hr.2015.69","volume":"38","author":"N Thamcharoen","year":"2015","unstructured":"Thamcharoen N, Susantitaphong P, Wongrakpanich S, Chongsathidkiet P, Tantrachoti P, Pitukweerakul S, Avihingsanon Y, Praditpornsilpa K, Jaber BL, Eiam-Ong S (2015) Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure, and kidney function in hypertensive patients: a meta-analysis. Hypertens Res 38:847\u2013855","journal-title":"Hypertens Res"},{"key":"4967_CR28","doi-asserted-by":"publisher","first-page":"f6008","DOI":"10.1136\/bmj.f6008","volume":"347","author":"HY Wu","year":"2013","unstructured":"Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL (2013) Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis. BMJ 347:f6008","journal-title":"BMJ"},{"key":"4967_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/hr.2016.85","volume":"40","author":"NR Robles","year":"2017","unstructured":"Robles NR, Fici F, Grassi G (2017) Dihydropyridine calcium channel blockers and renal disease. Hypertens Res 40:21\u201328","journal-title":"Hypertens Res"},{"key":"4967_CR30","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1046\/j.1523-1755.1999.00434.x","volume":"55","author":"KA Griffin","year":"1999","unstructured":"Griffin KA, Picken MM, Bakris GL, Bidani AK (1999) Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int 55:1849\u20131860","journal-title":"Kidney Int"},{"key":"4967_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jpeds.2004.04.009","volume":"145","author":"JT Flynn","year":"2004","unstructured":"Flynn JT, Newburger JW, Daniels SR, Sanders SP, Portman RJ, Hogg RJ, Saul JP, PATH-1 Investigators (2004) A randomized, placebo- controlled trial of amlodipine in children with hypertension. J Pediatr 145:353\u2013359","journal-title":"J Pediatr"},{"key":"4967_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00467-004-1781-9","volume":"20","author":"JT Flynn","year":"2005","unstructured":"Flynn JT (2005) Efficacy and safety of prolonged amlodipine treatment in hypertensive children. Pediatr Nephrol 20:631\u2013635","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-04967-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:42:54Z","timestamp":1625564574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-04967-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4967"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-04967-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"1 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB approval at all participating sites in the Chronic Kidney Disease in children prospective cohort study was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent\/assent was obtained from all individual participants\/parents included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author\u2019s own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}